Literature DB >> 29989580

[Suppression of NR0B2 gene in Clear Cell Renal Cell Carcinoma Is Associated with Hypermethylation of Its Promoter].

A V Kudryavtseva1,2,3, K M Nyushko2, A R Zaretsky4,5, D A Shagin4, A F Sadritdinova1,2, M S Fedorova1, M V Savvateeva1, Z G Guvatova1, E A Pudova1, B Y Alekseev2, A A Dmitriev1, A V Snezhkina1.   

Abstract

Clear cell renal cell carcinoma (ccRCC) is a common urologic malignancy. Understanding of the transcriptional regulation of oncogenes and tumor suppressor genes involved is critical for the development of the treatments for renal tumors. Using ccRCC subdivision of the TCGA dataset, we identified NR0B2 encoding orphan nuclear receptor as a tumor suppressor candidate in renal tissue. In independent cohort of primary renal tumors, quantitative PCR experiments confirmed significant suppression of NR0B2 mRNA in 86% of ccRCC samples studied. In 80% of these cases, we detected the hypermethylation of the NR0B2 pro-moter region. These results suggest that NR0B2 is a tumor suppressor gene in ccRCC, and that the hypermethylation of promoter region is the main mechanism of its downregulation.

Entities:  

Keywords:  DNA methylation; NR0B2; bisulfite sequencing; clear cell renal cell carcinoma; quantitative PCR; tumor suppressor gene

Mesh:

Substances:

Year:  2018        PMID: 29989580     DOI: 10.7868/S0026898418030114

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  3 in total

1.  Aberrant MFN2 transcription facilitates homocysteine-induced VSMCs proliferation via the increased binding of c-Myc to DNMT1 in atherosclerosis.

Authors:  Long Xu; Hongyi Hao; Yinju Hao; Guo Wei; Guizhong Li; Pengjun Ma; Lingbo Xu; Ning Ding; Shengchao Ma; Alex F Chen; Yideng Jiang
Journal:  J Cell Mol Med       Date:  2019-05-18       Impact factor: 5.310

2.  Differentially Expressed Genes Associated With Prognosis in Locally Advanced Lymph Node-Negative Prostate Cancer.

Authors:  Elena A Pudova; Elena N Lukyanova; Kirill M Nyushko; Dmitry S Mikhaylenko; Andrew R Zaretsky; Anastasiya V Snezhkina; Maria V Savvateeva; Anastasiya A Kobelyatskaya; Nataliya V Melnikova; Nadezhda N Volchenko; Gennady D Efremov; Kseniya M Klimina; Anastasiya A Belova; Marina V Kiseleva; Andrey D Kaprin; Boris Y Alekseev; George S Krasnov; Anna V Kudryavtseva
Journal:  Front Genet       Date:  2019-08-09       Impact factor: 4.599

3.  NETO2 Is Deregulated in Breast, Prostate, and Colorectal Cancer and Participates in Cellular Signaling.

Authors:  Maria S Fedorova; Anastasiya V Snezhkina; Anastasiya V Lipatova; Vladislav S Pavlov; Anastasiya A Kobelyatskaya; Zulfiya G Guvatova; Elena A Pudova; Maria V Savvateeva; Irina A Ishina; Tatiana B Demidova; Nadezhda N Volchenko; Dmitry Y Trofimov; Gennady T Sukhikh; George S Krasnov; Anna V Kudryavtseva
Journal:  Front Genet       Date:  2020-12-10       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.